Mechanism of Eccentric Cardiomyocyte Hypertrophy Secondary to Severe Mitral Regurgitation

Shujuan Li1,2,3, Ngoc Uyen Nhi Nguyen3, Feng Xiao3

  • 1Department of Pediatric Cardiology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China (S.L.).

Circulation
|April 11, 2020
PubMed

Insights

Severe mitral regurgitation (MR) causes left ventricular (LV) dysfunction through maladaptive eccentric cardiomyocyte hypertrophy. Targeting mTOR signaling and cell polarity pathways may prevent this cardiac remodeling.

Area of Science:

  • Cardiovascular Research
  • Molecular Cardiology
  • Cardiac Physiology

Background:

  • Primary valvular heart disease, especially mitral regurgitation (MR), is a major cause of heart failure.
  • Current treatments focus on valve repair/replacement, not preventing myocardial dysfunction.
  • The mechanisms driving left ventricular (LV) dysfunction in severe MR remain unknown.

Purpose of the Study:

  • To develop and characterize the first mouse model of severe MR.
  • To elucidate the underlying mechanisms of LV dysfunction in this model.
  • To identify potential therapeutic targets for MR-induced cardiac pathology.

Main Methods:

  • Induction of severe MR in mice by surgically damaging the mitral valve.
  • Serial echocardiography to assess LV morphology and function.
  • Histological and molecular analyses of cardiac tissues, including RNA-sequencing.

Main Results:

  • Induced MR led to progressive LV dilatation, eccentric hypertrophy, and severe systolic dysfunction over 15 weeks.
  • Cardiomyocyte length increased, with sarcomere disarray and disruption.
  • Activation of mTOR and calcineurin pathways was observed; mTOR inhibition preserved cardiac structure and function.
  • Differential expression of Crb2 and increased polysome localization near intercalated disks were noted.

Conclusions:

  • LV dysfunction in severe MR results from maladaptive eccentric cardiomyocyte hypertrophy.
  • Cell polarity regulation and localized protein synthesis are key pathways in MR-induced cardiomyocyte growth.
  • Targeting mTOR signaling offers a potential therapeutic strategy to prevent MR-induced cardiac remodeling.
Abstract

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
290
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
594
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
283
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
297
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
252
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
343